Market By Product, Application And End-user | Forecast 2019-2028
A Triton Market Research report has determined that the CRISPR market in the Middle East and Africa will prosper at CAGR of 24.08% during the projected period 2019-2028.
We provide additional customization based on your specific requirements. Request For Customization
The countries scrutinized in the Middle East and Africa market are:
• Turkey
• United Arab Emirates
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
Turkey is part of the Cartagena Protocol on Biosafety, which is an agreement aiming to ensure the safe handling of living modified organisms. The Biosafety Law and its associated rules, which were implemented in September 2010, regulate biosafety applications in Turkey. Although the country typically does not allow the use of genetically modified organisms for food, the biosecurity council in Turkey approved the utility of three varieties of genetically modified soybeans. Such conformation to the increasing use of genetically modified organisms for the foods is expected to prosper the demand for the CRISPR (Clustered Regularly Interspaced Short Palindrome Repeats) market in Turkey, thereby growing the market growth.
It is reported that the Antiviral Gene Therapy Research Unit (AGTRU) at Wits University is currently undertaking research activities to develop a cure for hepatitis B, which is a virus that destroys the liver. The research team made use of CRISPR-Cas9 and TALENS gene-editing technique to combat the virus. The team has also been working on gene editing techniques against tuberculosis, another major disease in South Africa. These developments in the field of gene therapy are likely to drive the CRISPR market growth in South Africa.
Established in 1987, Integrated DNA Technologies Inc is a company that is involved in the development and manufacturing of custom oligonucleotides for the research & diagnostics life science market. It provides its products to different areas of academic research, and pharmaceutical & biotechnological development. It is specialized in the areas of gene splicing, DNA sequencing, transcription profiling, SNP detection, and DNA amplification. The company has business operations in the Middle East.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Test Types, Technolo ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT1. MIDDLE EAST AND AFRICA CRISPR MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. VALUE CHAIN OUTLOOK
2.4. SUPPLY CHAIN OUTLOOK
2.5. TIMELINE OF CRISPR MARKET
2.6. PARENT MARKET OUTLOOK
2.7. KEY INSIGHT
2.8. MARKET ATTRACTIVENESS INDEX
2.9. MARKET DRIVERS
2.9.1. GROWING LIFESTYLE-ORIENTED DISEASES
2.9.2. SURGING PREVALENCE OF GENETIC DISEASES
2.9.3. INCREASING APPLICATION OF DRUGS
2.9.4. RISING AGING POPULATION
2.9.5. INCIDENCE OF GENETIC AILMENTS
2.10. MARKET RESTRAINTS
2.10.1. ETHICAL AND SOCIAL ISSUES ASSOCIATED WITH CRISPR TECHNOLOGY
2.10.2. CHANGING REGULATORY ENVIRONMENT
2.11. MARKET OPPORTUNITIES
2.11.1. INCREASED DEMAND FOR CRISPR
2.11.2. ADVANCEMENTS IN THE APPLICATIONS OF GENE-BASED THERAPY
2.12. MARKET CHALLENGES
2.12.1. ALTERNATIVE TECHNOLOGIES
2.12.2. LACK OF AWARENESS REGARDING THE TECHNOLOGY
3. CRISPR MARKET OUTLOOK - BY PRODUCT
3.1. PLASMIDS
3.2. VECTORS
3.3. PROTEINS
3.4. DESIGN TOOLS
3.5. GRNA
3.6. CONTROL KITS
3.7. LIBRARY
3.8. OTHER PRODUCTS
4. CRISPR MARKET OUTLOOK - BY APPLICATION
4.1. GENOME EDITING/GENETIC ENGINEERING
4.2. GRNA DATABASE/GENE LIBRARY
4.3. CRISPR PLASMID
4.4. HUMAN STEM CELLS
4.5. CELL LINE ENGINEERING
5. CRISPR MARKET OUTLOOK - BY END-USER
5.1. THERAPEUTICS & DRUG DISCOVERY
5.2. BIOLOGICAL RESEARCH
5.3. AGRICULTURAL BIOTECH
5.4. INDUSTRIAL BIOTECH
6. CRISPR MARKET – MIDDLE EAST AND AFRICA
6.1. SAUDI ARABIA
6.2. TURKEY
6.3. UNITED ARAB EMIRATES
6.4. SOUTH AFRICA
6.5. REST OF MIDDLE EAST & AFRICA
7. COMPANY PROFILE
7.1. ADDGENE
7.2. APPLIED STEMCELL
7.3. CARIBOU BIOSCIENCES INC
7.4. CELLECTIS
7.5. CRISPR THERAPEUTICS
7.6. DIACARTA
7.7. EDITAS MEDICINE
7.8. GENECOPOEIA INC
7.9. GENEDATA AG
7.10. GENSCRIPT
7.11. HORIZON DISCOVERY LTD
7.12. INTEGRATED DNA TECHNOLOGIES INC
7.13. INTELLIA THERAPEUTICS INC
7.14. LONZA
7.15. NEW ENGLAND BIOLABS
7.16. ORIGENE TECHNOLOGIES INC
7.17. PRECISION BIOSCIENCES
7.18. SANGAMO THERAPEUTICS
7.19. SIGMA-ALDRICH (MERCK KGAA)
7.20. THERMO FISHER SCIENTIFIC INC
7.21. TRANSPOSAGEN BIO (HERA BIOLABS)
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 MIDDLE EAST AND AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)
TABLE 2 CHIEF CONCERNS RELATED TO GENETIC ENGINEERING
TABLE 3 MIDDLE EAST AND AFRICA CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)
TABLE 4 TOOL NAMES AND THEIR PROVIDERS
TABLE 5 MIDDLE EAST AND AFRICA CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)
TABLE 6 BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET
TABLE 7 AGRICULTURE BIOTECH TRAITS INDUSTRY
TABLE 8 MIDDLE EAST AND AFRICA CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)
TABLE 9 MIDDLE EAST AND AFRICA CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 MIDDLE EAST AND AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)
FIGURE 2 VALUE CHAIN ANALYSIS
FIGURE 3 MIDDLE EAST AND AFRICA CRISPR MARKET, BY PLASMIDS, 2019-2028 ($ MILLION)
FIGURE 4 MIDDLE EAST AND AFRICA CRISPR MARKET, BY VECTORS, 2019-2028 ($ MILLION)
FIGURE 5 MIDDLE EAST AND AFRICA CRISPR MARKET, BY PROTEINS, 2019-2028 ($ MILLION)
FIGURE 6 MIDDLE EAST AND AFRICA CRISPR MARKET, BY DESIGN TOOLS, 2019-2028 ($ MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA CRISPR MARKET, BY GRNA, 2019-2028 ($ MILLION)
FIGURE 8 MIDDLE EAST AND AFRICA CRISPR MARKET, BY CONTROL KITS, 2019-2028 ($ MILLION)
FIGURE 9 MIDDLE EAST AND AFRICA CRISPR MARKET, BY LIBRARY, 2019-2028 ($ MILLION)
FIGURE 10 MIDDLE EAST AND AFRICA CRISPR MARKET, BY OTHER PRODUCTS, 2019-2028 ($ MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2019-2028 ($ MILLION)
FIGURE 12 MIDDLE EAST AND AFRICA CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2019-2028 ($ MILLION)
FIGURE 13 MIDDLE EAST AND AFRICA CRISPR MARKET, BY CRISPR PLASMID, 2019-2028 ($ MILLION)
FIGURE 14 MIDDLE EAST AND AFRICA CRISPR MARKET, BY HUMAN STEM CELLS, 2019-2028 ($ MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA CRISPR MARKET, BY CELL LINE ENGINEERING, 2019-2028 ($ MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2019-2028 ($ MILLION)
FIGURE 17 MIDDLE EAST AND AFRICA CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2019-2028 ($ MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2019-2028 ($ MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2019-2028 ($ MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)
FIGURE 21 SAUDI ARABIA CRISPR MARKET, 2019-2028 ($ MILLION)
FIGURE 22 TURKEY CRISPR MARKET, 2019-2028 ($ MILLION)
FIGURE 23 UNITED ARAB EMIRATES CRISPR MARKET, 2019-2028 ($ MILLION)
FIGURE 24 SOUTH AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)
FIGURE 25 REST OF MIDDLE EAST & AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)